Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tallini

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Human Pathology|August 1, 1996
Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infectionS Rosini, S Caltagirone, G Tallini, et al.
Archives of Pathology & Laboratory Medicine|September 7, 2000
Epstein-Barr virus RNA detection and glandular differentiation in nasopharyngeal carcinoma: report of 2 casesD Jain, V Parkash, M Li, et al.
The Journal of Clinical Investigation|February 2, 1999
p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinomaM Fornaro, G Tallini, D Q Zheng, et al.
Prenatal Diagnosis|November 1, 1991
Prenatal diagnosis of a fetus with terminal deletion of chromosome 1 (q41)S Rotmensch, M Liberati, J S Luo, et al.
Kidney International|May 1, 1997
Modulation of cell proliferation by the integrin cytoplasmic domainD Q Zheng, M Fornaro, C J Bofetiado, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 1999
Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridizationG Tallini, A Hsueh, S Liu, et al.
The American Journal of Pathology|April 1, 1994
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiationG Tallini, D M Parham, P Dias, et al.
The American Journal of Pathology|March 10, 2001
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosisG Garcia-Rostan, R L Camp, A Herrero, et al.
Journal of Clinical Gastroenterology|January 23, 1999
Biliary tract obstruction secondary to mycosis fungoides: a case reportJ A Madsen, G Tallini, E J Glusac, et al.
Cancer Research|April 23, 1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinomaG Garcia-Rostan, G Tallini, A Herrero, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Human Pathology|August 1, 1996
Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infectionS Rosini, S Caltagirone, G Tallini, et al.
Archives of Pathology & Laboratory Medicine|September 7, 2000
Epstein-Barr virus RNA detection and glandular differentiation in nasopharyngeal carcinoma: report of 2 casesD Jain, V Parkash, M Li, et al.
The Journal of Clinical Investigation|February 2, 1999
p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinomaM Fornaro, G Tallini, D Q Zheng, et al.
Prenatal Diagnosis|November 1, 1991
Prenatal diagnosis of a fetus with terminal deletion of chromosome 1 (q41)S Rotmensch, M Liberati, J S Luo, et al.
Kidney International|May 1, 1997
Modulation of cell proliferation by the integrin cytoplasmic domainD Q Zheng, M Fornaro, C J Bofetiado, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 1999
Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridizationG Tallini, A Hsueh, S Liu, et al.
The American Journal of Pathology|April 1, 1994
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiationG Tallini, D M Parham, P Dias, et al.
The American Journal of Pathology|March 10, 2001
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosisG Garcia-Rostan, R L Camp, A Herrero, et al.
Journal of Clinical Gastroenterology|January 23, 1999
Biliary tract obstruction secondary to mycosis fungoides: a case reportJ A Madsen, G Tallini, E J Glusac, et al.
Cancer Research|April 23, 1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinomaG Garcia-Rostan, G Tallini, A Herrero, et al.
Pageof 9